While tobacco and alcohol are known to increase the risk of head and neck cancer, new research has found the amount of coffee ...

CTX-471 is under clinical development by Compass Therapeutics and currently in Phase I for Head And Neck Cancer.

PAX-1 is under clinical development by Komipharm International and currently in Phase I for Head And Neck Cancer.

The Jimmy Carter drug introduced the world to cancer immunotherapy, a treatment that differs from chemotherapy. Carter was ...

Obsessed with chai Or Coffee Well its your day to be happy Recent research suggests that this daily ritual might be lowering ...

Rahway, NJ, USA) anti-PD-1 therapy KEYTRUDA® (pembrolizumab) in first line recurrent/metastatic head ... this novel IO combination in head and neck squamous cell cancers with PD-L1 CPS <1.

GORTEC, known as Head and Neck Radiation Oncology Group, today announced that the randomized Phase 3 NIVOPOSTOP GORTEC ...

In the latest statistical salvo of an ongoing debate, people who consumed more than four cups of caffeinated coffee daily had ...

In an analysis of data from more than a dozen studies, coffee and tea consumption was linked with lower risks of developing head and neck cancer, including cancers of the mouth and throat.